Lilly unveils biotech facility in San Diego
Eli Lilly and Co. opened a biotech facility in San Diego, where it plans to develop and test biotech drugs for cancer, diabetes and autoimmune diseases. The 100,000-square-foot facility is strategically located to allow the company to work with scientists from nearby universities and research centers.
Indianapolis Star, The | 10/29
This story published in BIO SmartBrief on 10/30/2009
More from SmartBrief:
Pathway Genomics unveils $250 genetic-testing service
Thursday, July 16, 2009
Sequenom faces fraud suit from Xenomics
Friday, October 30, 2009
FDA clears prasugrel, requires black-box warning
Monday, July 13, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|